Managing AI Expectations in Healthcare R&D
The Wall Street Journal Health Forum
Washington, D.C., April 30, 2019
Moderated by Kathy Gibson (Chief Innovation Officer, CAS) and featuring AI experts from CAS, Pfizer, and Vyasa Analytics, this CAS-hosted panel discussion explores the huge potential of emerging big data technologies, such as AI (artificial intelligence), to improve health care and accelerate drug development.
The discussion highlights how healthcare R&D organizations are already leveraging these technologies today and what approaches and investments are needed to maximize their potential in the future.
View this preview video, or watch a recording of the full session.